+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Oncology Drugs Market Research Reports

From
T-Cell Blood Cancer - Pipeline Insight, 2025 - Product Thumbnail Image

T-Cell Blood Cancer - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
CNS Lymphoma - Pipeline Insight, 2025 - Product Thumbnail Image

CNS Lymphoma - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Nevoid Basal Cell Carcinoma Syndrome (NBCCS) - Pipeline Insight, 2025 - Product Thumbnail Image

Nevoid Basal Cell Carcinoma Syndrome (NBCCS) - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
From
Zollinger Ellison Syndrome - Pipeline Insight, 2025 - Product Thumbnail Image

Zollinger Ellison Syndrome - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
IPSC Derived NK Cells- Pipeline Insight, 2025 - Product Thumbnail Image

IPSC Derived NK Cells- Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Ependymoma - Pipeline Insight, 2025 - Product Thumbnail Image

Ependymoma - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Metastatic Cutaneous Squamous Cell Cancer - Pipeline Insight, 2025 - Product Thumbnail Image

Metastatic Cutaneous Squamous Cell Cancer - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Squamous Cell Carcinoma - Pipeline Insight, 2025 - Product Thumbnail Image

Squamous Cell Carcinoma - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 240 Pages
  • Global
From
Collagen Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

Collagen Inhibitors - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 50 Pages
  • Global
From
Antibody Drug Conjugate - Competitive Landscape, 2025 - Product Thumbnail Image

Antibody Drug Conjugate - Competitive Landscape, 2025

  • Report
  • March 2025
  • 450 Pages
  • Global
From
From
Cervical Cancer - Epidemiology Forecast - 2034 - Product Thumbnail Image

Cervical Cancer - Epidemiology Forecast - 2034

  • Report
  • December 2024
  • 112 Pages
  • Global
From
Pancreatic Cancer - Competitive Landscape, 2024 - Product Thumbnail Image

Pancreatic Cancer - Competitive Landscape, 2024

  • Clinical Trials
  • December 2024
  • 550 Pages
  • Global
From
Esophageal Cancer - Epidemiology Forecast - 2034 - Product Thumbnail Image

Esophageal Cancer - Epidemiology Forecast - 2034

  • Report
  • December 2024
  • 122 Pages
  • Global
From
Peripheral T-Cell Lymphoma - Epidemiology Forecast - 2034 - Product Thumbnail Image

Peripheral T-Cell Lymphoma - Epidemiology Forecast - 2034

  • Report
  • December 2024
  • 114 Pages
  • Global
From
Myelofibrosis - Epidemiology Forecast - 2034 - Product Thumbnail Image

Myelofibrosis - Epidemiology Forecast - 2034

  • Report
  • December 2024
  • 131 Pages
  • Global
From
Adrenocortical Carcinoma - Epidemiology Forecast - 2034 - Product Thumbnail Image

Adrenocortical Carcinoma - Epidemiology Forecast - 2034

  • Report
  • December 2024
  • 71 Pages
  • Global
From
Ocular Melanoma - Epidemiology Forecast - 2034 - Product Thumbnail Image

Ocular Melanoma - Epidemiology Forecast - 2034

  • Report
  • December 2024
  • 71 Pages
  • Global
From
Loading Indicator

The Oncology Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat cancer. These drugs are used to treat a variety of cancers, including breast, lung, and prostate cancer. Oncology drugs are typically administered intravenously or orally, and can be used in combination with other treatments such as radiation and chemotherapy. The Oncology Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Bristol-Myers Squibb, Merck & Co., Pfizer, Novartis, and Roche. These companies are constantly researching and developing new drugs to treat cancer, as well as improving existing treatments. Additionally, many smaller companies are also involved in the Oncology Drugs market, providing innovative treatments and therapies. Show Less Read more